AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 2 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2013 | $309,000 | -17.6% | 150,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $375,000 | -60.8% | 150,000 | +15.4% | 0.00% | -66.7% |
Q1 2013 | $956,000 | -8.7% | 130,000 | 0.0% | 0.00% | -25.0% |
Q4 2012 | $1,047,000 | +11.7% | 130,000 | +44.4% | 0.00% | 0.0% |
Q3 2012 | $937,000 | -14.4% | 90,000 | 0.0% | 0.00% | -20.0% |
Q2 2012 | $1,094,000 | +17.5% | 90,000 | +20.0% | 0.01% | +25.0% |
Q1 2012 | $931,000 | – | 75,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
Caption Management, LLC | 748,200 | $503,000 | 0.02% |
Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |